LQDA - NASDAQ

Liquidia Corporation

LQDA·NASDAQ

$55.69

+1.5%

HealthcareBiotechnology

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil injection in the United States. Liquidia Corporation was founded in 2004 and is headquartered in Morrisville, North Carolina.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$4.95B

EPS-0.8000

P/E Ratio-69.61

Earnings Date08/11/2026

lqda

Cash at Beginning of Period

Last Annual Value

176.48M

3-Year CAGR

45%

5-Year CAGR

26%

10-Year CAGR

31%

Adjust for Inflation

Liquidia Corporation Competitors Analysis of Cash at Beginning of Period

LQDA · NASDAQ

Company	Cash at Beginning of Period	CAGR 3Y	CAGR 5Y	CAGR 10Y
Liquidia Corporation NASDAQ:LQDA	176.48M	23.7%	22.0%	30.7%
Cogent Biosciences, Inc. NASDAQ:COGT	98.17M	-11.4%	-16.6%	0.8%
Structure Therapeutics Inc. NASDAQ:GPCR	169.51M	86.6%	59.6%	N/A
Denali Therapeutics Inc. NASDAQ:DNLI	176.53M	-6.8%	-19.1%	19.1%
89bio, Inc. NASDAQ:ETNB	316.16M	78.9%	26.3%	N/A
ImmunityBio, Inc. NASDAQ:IBRX	143.91M	11.1%	32.6%	-2.0%
Arcus Biosciences, Inc. NYSE:RCUS	153.00M	-9.9%	-2.5%	12.6%
Ocular Therapeutix, Inc. NASDAQ:OCUL	393.72M	55.8%	11.4%	29.0%
Agios Pharmaceuticals, Inc. NASDAQ:AGIO	76.25M	-18.2%	-9.8%	0.6%

Liquidia Corporation Fair Value Envelope

LQDA · NASDAQ

Our analysis suggests that LQDA has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $55.69, this represents a potential HIDDEN relative to our calculated worth for Liquidia Corporation.

HIDDEN

Intrinsic Value

Current Price: $55.69

Related Guides

Blog Categories

Continue your LQDA research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.